These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
268 related articles for article (PubMed ID: 19231202)
1. Inhibition of Trypanosoma brucei glucose-6-phosphate dehydrogenase by human steroids and their effects on the viability of cultured parasites. Cordeiro AT; Thiemann OH; Michels PA Bioorg Med Chem; 2009 Mar; 17(6):2483-9. PubMed ID: 19231202 [TBL] [Abstract][Full Text] [Related]
2. 16-bromoepiandrosterone, an activator of the mammalian immune system, inhibits glucose 6-phosphate dehydrogenase from Trypanosoma cruzi and is toxic to these parasites grown in culture. Cordeiro AT; Thiemann OH Bioorg Med Chem; 2010 Jul; 18(13):4762-8. PubMed ID: 20570159 [TBL] [Abstract][Full Text] [Related]
3. Glucose-6-phosphate dehydrogenase is the target for the trypanocidal action of human steroids. Gupta S; Cordeiro AT; Michels PA Mol Biochem Parasitol; 2011 Apr; 176(2):112-5. PubMed ID: 21185333 [TBL] [Abstract][Full Text] [Related]
4. Glucose 6-Phosphate Dehydrogenase from Trypanosomes: Selectivity for Steroids and Chemical Validation in Bloodstream Ortíz C; Moraca F; Laverriere M; Jordan A; Hamilton N; Comini MA Molecules; 2021 Jan; 26(2):. PubMed ID: 33445584 [TBL] [Abstract][Full Text] [Related]
5. On the mechanism of interaction of steroids with human glucose 6-phosphate dehydrogenase. Gordon G; Mackow MC; Levy HR Arch Biochem Biophys; 1995 Apr; 318(1):25-9. PubMed ID: 7726568 [TBL] [Abstract][Full Text] [Related]
6. The glucose-6-phosphate dehydrogenase from Trypanosoma cruzi: its role in the defense of the parasite against oxidative stress. Igoillo-Esteve M; Cazzulo JJ Mol Biochem Parasitol; 2006 Oct; 149(2):170-81. PubMed ID: 16828178 [TBL] [Abstract][Full Text] [Related]
13. Binding Mode and Selectivity of Steroids towards Glucose-6-phosphate Dehydrogenase from the Pathogen Trypanosoma cruzi. Ortiz C; Moraca F; Medeiros A; Botta M; Hamilton N; Comini MA Molecules; 2016 Mar; 21(3):368. PubMed ID: 26999093 [TBL] [Abstract][Full Text] [Related]
15. Discovery of new uncompetitive inhibitors of glucose-6-phosphate dehydrogenase. Mercaldi GF; Ranzani AT; Cordeiro AT J Biomol Screen; 2014 Dec; 19(10):1362-71. PubMed ID: 25121555 [TBL] [Abstract][Full Text] [Related]
16. Chemical validation of GPI biosynthesis as a drug target against African sleeping sickness. Smith TK; Crossman A; Brimacombe JS; Ferguson MA EMBO J; 2004 Nov; 23(23):4701-8. PubMed ID: 15526036 [TBL] [Abstract][Full Text] [Related]
17. Design and synthesis of peptidomimetic protein farnesyltransferase inhibitors as anti-Trypanosoma brucei agents. Ohkanda J; Buckner FS; Lockman JW; Yokoyama K; Carrico D; Eastman R; de Luca-Fradley K; Davies W; Croft SL; Van Voorhis WC; Gelb MH; Sebti SM; Hamilton AD J Med Chem; 2004 Jan; 47(2):432-45. PubMed ID: 14711313 [TBL] [Abstract][Full Text] [Related]
18. NADPH Producing Enzymes as Promising Drug Targets for Chagas Disease. Cordeiro AT Curr Med Chem; 2019; 26(36):6564-6571. PubMed ID: 30306853 [TBL] [Abstract][Full Text] [Related]
19. Dehydroepiandrosterone increased oxidative stress in a human cell line during differentiation. Izumo K; Horiuchi M; Komatsu M; Aoyama K; Bandow K; Matsuguchi T; Takeuchi M; Takeuchi T Free Radic Res; 2009 Oct; 43(10):922-31. PubMed ID: 19680996 [TBL] [Abstract][Full Text] [Related]
20. The enzymes of the classical pentose phosphate pathway display differential activities in procyclic and bloodstream forms of Trypanosoma brucei. Cronín CN; Nolan DP; Voorheis HP FEBS Lett; 1989 Feb; 244(1):26-30. PubMed ID: 2924907 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]